Amgen PT Raised to $440 at Cantor Fitzgerald
Bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish
What happened, with direct paths to the underlying reporting
AMGN received an analyst target update from Cantor Fitzgerald.
Target: $440
Posted price: $413.08
Analyst firm: Cantor Fitzgerald
Analyst: Carter Gould
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.